Merrimack Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
Merrimack Pharmaceuticals, Inc. Earnings Date And Information
Merrimack Pharmaceuticals, Inc. last posted its earnings results on Wednesday, March 6th, 2019. The company reported $-0.97 earnings per share for the quarter, topping analysts' consensus estimates of $-1.01 by $0.04. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Merrimack Pharmaceuticals, Inc. has generated $0 earnings per share over the last year ($-0.0826 diluted earnings per share) and currently has a price-to-earnings ratio of -8.92. Merrimack Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based on prior year's report dates.
Merrimack Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/15/2024 | Q1 2024 | -$1.64 | $0 | $0 | ||
| 03/07/2024 | Q4 2023 | -$0.02 | $0 | |||
| 11/02/2023 | Q3 2023 | -$0.02 | $0 | |||
| 08/03/2023 | Q2 2023 | -$0.03 | $0 | |||
| 05/04/2023 | Q1 2023 | -$0.01 | $0 | |||
| 03/09/2023 | Q4 2022 | -$0.04 | $-445,000 | |||
| 11/03/2022 | Q3 2022 | -$0.02 | $0 | |||
| 08/04/2022 | Q2 2022 | -$0.03 | $0 | |||
| 05/05/2022 | Q1 2022 | -$0.01 | $0 | |||
| 03/09/2022 | Q4 2021 | -$0.04 | $0 | |||
| 11/04/2021 | Q3 2021 | -$0.04 | $0 | |||
| 08/05/2021 | Q2 2021 | -$0.06 | $0 | |||
| 05/06/2021 | Q1 2021 | -$0.05 | $0 | |||
| 03/10/2021 | Q4 2020 | -$0.08 | $0 | |||
| 11/04/2020 | Q3 2020 | -$0.08 | $0 | |||
| 08/07/2020 | Q2 2020 | -$0.09 | $0 | |||
| 05/07/2020 | Q1 2020 | $0.02 | $0 | |||
| 03/12/2020 | Q4 2019 | $0.24 | $0 | |||
| 11/12/2019 | Q3 2019 | -$0.05 | $0 | |||
| 07/17/2019 | Q2 2019 | -$0.71 | $0 |
Merrimack Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Merrimack Pharmaceuticals, Inc.'s earnings date?
Merrimack Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates.
-
Did Merrimack Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Merrimack Pharmaceuticals, Inc. (:MACK) reported $-0.97 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.01 by $0.04.
-
How can I listen to Merrimack Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Merrimack Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Merrimack Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Merrimack Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Merrimack Pharmaceuticals, Inc. generate each year?
Merrimack Pharmaceuticals, Inc. (:MACK) has a recorded net income of $0. Merrimack Pharmaceuticals, Inc. has generated $-0.0826 earnings per share over the last four quarters.
-
What is Merrimack Pharmaceuticals, Inc.'s price-to-earnings ratio?
Merrimack Pharmaceuticals, Inc. (:MACK) has a price-to-earnings ratio of -8.92 and price/earnings-to-growth ratio is 0.
